Pharma Mar SAU (PHMR)

70.840
-0.460(-0.65%)
  • Volume:
    16,861
  • Bid/Ask:
    70.800/70.880
  • Day's Range:
    70.240 - 71.540
  • Type:Equity
  • Market:Spain
  • ISIN:ES0169501022

PHMR Overview

Prev. Close
71.3
Day's Range
70.24-71.54
Revenue
199.55M
Open
70.93
52 wk Range
66.7-129.9
EPS
4.95
Volume
16,861
Market Cap
1.3B
Dividend (Yield)
0.60
(0.80%)
Average Volume (3m)
86,283
P/E Ratio
15.61
Beta
-0.15
1-Year Change
-38.75%
Shares Outstanding
18,112,907
Next Earnings Date
26 Oct 2021
What is your sentiment on Pharma Mar SAU?
or
Vote to see community's results!

Pharma Mar SAU News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellNeutral
Technical IndicatorsStrong SellStrong SellSellSellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellSell

Pharma Mar SAU Company Profile

Pharma Mar SAU Company Profile

Employees
443
Market
Spain

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, rest of Europe, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissue sarcomas and for ovarian cancer; Aplidin for treating multiple myeloma; and Zepzelca for treating patients with small cell lung cancer. The company also develops clinical-stage programs, including PM184 and PM14. In addition, it develops and markets diagnostics kits; and develops drugs with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was incorporated in 1986 and is based in Madrid, Spain.

Read More
  • Facing 148 again in no time.
    0
    • Where is your assertivity coming from, technically there is no signal it will hapoen
      0
  • Will go to the top again
    0
    • Up!, Up!, Up!!
      0
      • Next step: Phase III for coronavirus antiviral. 🚀🚀🚀
        0
        • https://www.gov.uk/government/news/government-invests-in-uk-developed-antibody-tests-from-uk-rapid-test-consortium
          0
          • very bullish
            0
            • Anyone know what's happening with this at the moment?
              0
              • I found this on trading 212
                0
                • Why cant I find this company on my trading platform?
                  0
                  • very bullish
                    0
                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.